Gene · 4880
Papers1,757
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,757
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advancements and Challenges in Tissue-Engineered Heart Valves: Integrating Biomechanics, Biomaterials, and Biomimetic Design for Functional Maturity. | Biomimetics (Basel) | 2026 | 41892108 | PubTator, text mining | PubMed |
| Effect of vosoritide on spine morphology in children with achondroplasia: 1-year results from a randomized phase 2 study. | J Endocr Soc | 2026 | 41783511 | PubTator, text mining | PubMed |
| Effect of vosoritide on genu varum in children with achondroplasia after 1 year in randomized placebo-controlled trials. | J Endocr Soc | 2026 | 41766933 | PubTator, text mining | PubMed |
| Development of Muscle Function in Children with Achondroplasia Under Vosoritide Treatment: A Retrospective Single-Centre Observational Study. | J Musculoskelet Neuronal Interact | 2026 | 41764752 | PubTator, text mining | PubMed |
| Novel Stochastic Sensors Based on Phthalocyanine Complexes for the Detection of C-NP, IL-6, and CRP in Cardiovascular Diseases. | Life (Basel) | 2026 | 41752974 | PubTator, text mining | PubMed |
| Neuroregulatory Biomaterials for Intervertebral Disc Regeneration via Neuro-Disc Microenvironment Modulation. | Research (Wash D C) | 2026 | 41705153 | PubTator, text mining | PubMed |
| Spatial transcriptomics identifies IL-32 as a lipid droplet-associated cytokine linked to tubular injury in human diabetic kidney disease. | Inflamm Res | 2026 | 41653322 | PubTator, text mining | PubMed |
| Exploring adverse events associated with vosoritide monotherapy: Insights from the FDA Adverse Event Reporting System. | PLoS One | 2026 | 41610120 | PubTator, text mining | PubMed |
| Functional analysis of NPR2 variants supports the therapeutic rationale for CNP in short stature. | Am J Hum Genet | 2026 | 41512838 | PubTator, text mining | PubMed |
| Restless Leg Syndrome and Association with Serum NT Pro-CNP. | Neurol India | 2026 | 41510866 | PubTator, text mining | PubMed |
| Pathophysiological and therapeutic implications of C-type natriuretic peptide/cyclic GMP signaling in pulmonary fibrosis. | JCI Insight | 2026 | 41499484 | PubTator, text mining | PubMed |
| C-type natriuretic peptide as mediator of growth in the absence of growth hormone: Unraveling the mystery of the growth without GH syndrome. | Hormones (Athens) | 2026 | 41396236 | PubTator, text mining | PubMed |
| Once-Weekly Navepegritide in Children With Achondroplasia: The APPROACH Randomized Clinical Trial. | JAMA Pediatr | 2026 | 41247754 | PubTator, text mining | PubMed |
| Real-world safety and age-dependent effectiveness of vosoritide in achondroplasia: A single-center retrospective analysis of transition from growth hormone to vosoritide. | Bone | 2026 | 41232919 | PubTator, text mining | PubMed |
| Effect of Vosoritide Therapy on IGF-I and Endogenous C-Type Natriuretic Peptide in Hypochondroplasia. | J Clin Endocrinol Metab | 2026 | 41157964 | PubTator, text mining | PubMed |
| Hypertensive Pregnancy Disorders: From Mechanisms to Management. | Am J Hypertens | 2026 | 40336354 | PubTator, text mining | PubMed |
| Phase 2 Trial of Vosoritide Use in Patients with Hypochondroplasia: A Pharmacokinetic/Pharmacodynamic Analysis. | Horm Res Paediatr | 2026 | 39427650 | PubTator, text mining | PubMed |
| A special perspective on human fertilization: The role of sperm capacitation proteins and channels: A narrative review. | Int J Reprod Biomed | 2025 | 41782698 | PubTator, text mining | PubMed |
| Saudi Heart Association Position Statement on NT-proBNP for Cardiovascular Risk Screening in Asymptomatic Adults With Type 2 Diabetes Mellitus. | J Saudi Heart Assoc | 2025 | 41769674 | PubTator, text mining | PubMed |
| New directions in growth hormone treatment in children. | Pediatr Endocrinol Diabetes Metab | 2025 | 41693185 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4880/papers?page=2